What CEPHALON INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Buchi J Kevin | Chief Executive Officer | Oct 14 | Disposition to Issuer · D | −2,592 | — | — | 0 |
| Buchi J Kevin | Chief Executive Officer | Oct 14 | Disposition to Issuer · D | −172,962 | — | — | 0 |
| Greenacre Martyn D | Director | Oct 14 | Disposition to Issuer · D | −200 | — | — | 0 |
| Egan William P | Director | Oct 14 | Disposition to Issuer · D | −21,661 | — | — | 0 |
| Moley Kevin E | Director | Oct 14 | Disposition to Issuer · D | −1,000 | — | — | 0 |
| Groehhuysen Wilco | Exec VP & CFO | Oct 14 | Disposition to Issuer · D | −42,717 | — | — | 0 |
| Baldassano Valli F. | Exec VP, Chief Compliance Off | Oct 14 | Disposition to Issuer · D | −73,555 | — | — | 0 |
| Sayini Carl A | Exec VP, Chief Admin Off | Oct 14 | Disposition to Issuer · D | −2,355 | — | — | 0 |
| Sayini Carl A | Exec VP, Chief Admin Off | Oct 14 | Disposition to Issuer · D | −84,677 | — | — | 0 |
| Aragues Alain | Exec VP, President Europe | Oct 14 | Disposition to Issuer · D | −42,275 | — | — | 0 |
| Pappert Gerald J. | Exec VP & General Counsel | Oct 14 | Disposition to Issuer · D | −75,193 | — | — | 0 |
| Russell Lesley | Exec VP, Chief Medical Off | Oct 14 | Disposition to Issuer · D | −367 | — | — | 0 |
| Russell Lesley | Exec VP, Chief Medical Off | Oct 14 | Disposition to Issuer · D | −101,228 | — | — | 0 |
| Vaught Jeffry L | Exec VP, Chief Scientific Off | Oct 14 | Disposition to Issuer · D | −189 | — | — | 0 |
| Vaught Jeffry L | Exec VP, Chief Scientific Off | Oct 14 | Disposition to Issuer · D | −98,431 | — | — | 0 |
| Greenacre Martyn D | Director | May 09 | Open-market sale · S | −4,206 | $79.71 | −$335K | 0 |
| Greenacre Martyn D | Director | May 09 | Open-market sale · S | −5,794 | $79.72 | −$462K | 4,206 |
| Greenacre Martyn D | Director | May 09 | Exercise / conversion · M | +10,000 | $63.98 | +$640K | 10,000 |
| Egan William P | Director | May 06 | Open-market sale · S | −10,000 | $79.89 | −$799K | 0 |
| Egan William P | Director | May 06 | Exercise / conversion · M | +10,000 | $63.98 | +$640K | 10,000 |
Loading...